Clinical Trial Update: Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer [Phase 1]

View source ↗

Summary

This report summarizes safety and tolerability data from a Phase 1 study of FolateImmune in combination with cytokines in patients with refractory or metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Cytokines (unspecified)
• FolateImmune

Snippet

Sponsor: Endocyte | Conditions: Cancer | Phase 1 | Status: COMPLETED